2 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard ChemotherapyExtrapulmonary Neuroendocrine Cancer (epNEC)RecruitingPhase 32026-09-29NCT07544654
A Prospective Longitudinal Study in Adults With Multifocal Motor Neuropathymultifocal motor neuropathyActive, not recruitingNot stated2026-05-29NCT05988073